Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification

Figure 3

Landscape of genetic and expression variations of SLC24A3 in CESC. (a) The mutation frequency of SLC24A3 in CESC. (b) The Kaplan-Meier survival curve estimated in accordance with amplification, deletion, and normal SLC24A3-mutated tumor of CNV. (c) The association between copy number of variation derived from methylation and expression of SLC24A3. (d) The overall survival curve of methylation status of SLC24A3. (e) Box plot showed the relation between methylation status of SLC24A3 and CNV amplification (red), deletion (blue), and non-CNV (orange) in the TCGA-CESC cohort. (f) Box plot showed the relation between SLC24A3 expression and CNV amplification (red), deletion (blue), and non-CNV (orange) in the TCGA-CESC cohort. (g, h) The forest plots for univariate Cox regression analysis and multivariate Cox regression analysis in TCGA-CESC cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)